MedTrace Logo

Hormone and Information Processing Study

NCT00539305 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2014-07-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the effects of testosterone (T) replacement on changes in thinking and memory, as well as mood in older men with mild cognitive impairment (MCI) and low T levels. The study will also examine whether taking testosterone has effects on biological markers related to Alzheimer's disease.

Conditions

Interventions

DRUG

testosterone gel

50-100mg applied topically daily for six months

DRUG

placebo gel

applied topically daily for six months

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Solvay Pharmaceuticals

    collaborator INDUSTRY

  • University of Washington

    lead OTHER

Principal Investigators

  • Monique Cherrier, PhD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-07-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00539305 on ClinicalTrials.gov